Cécile holds a Ph.D in fundamental Virology. Her research background focused on two human viruses: she first carried out research on Interferon antiviral effect against Hepatitis B virus, as a PhD fellow at Inserm U370/Institute Pasteur Paris, Pr. C. Bréchot’s Lab. As a postdoctoral research associate, she joined the Department of Immunology of Imperial College (London, UK), directed by Professor. C.R.M Bangham, to conduct a research project on Human T Lymphotropic Virus type 1 (HTLV-1) transmission. For 16 years, she then acquired a long experience in biomedical research programmes management and running collaborations in public-private partnerships, combining expertise in fundamental virology, immunology, vaccinology and clinical research. Since 2015, Cécile worked at Institut Pasteur, contributing to the development of its Carnot Pasteur Microbes & Health research and innovation programme and to the implementation of the scientific strategy of the institute, working in close collaboration with the Computational Biology, Virology and Global Health departments. In Oct. 2021, she joined the ANRS- Emerging Infectious Diseases (ANRS-MIE), as the head of its Basic Research Departement, to contribute to scientific prospective, funding schemes, animation & coordination of research on Emerging Infectious diseases, HIV/AIDS, Tuberculosis, STIs and Viral Hepatitis. Since January 2025, as department scientific manager at Institut Pasteur, she is managing the following 3 departments: (i) Immunology, (ii) Cell Biology of Infection and (iii) Developmental & Stem Cell Biology.
Click to view graph
Connections
Click to view timeline
Timeline
Former Teams
Publications
Download-
2020
-
2018HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates, PLoS ONE 2018;13(11):e0207794.
-
2005Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice, J. Hepatol. 2005 Dec;43(6):965-72.
-
2005[Wide range antiviral activity of MxA protein]., Virologie (Montrouge) 2005 Jun; 9(3): 229-237.
-
2001Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein, J. Virol. 2001 Mar;75(6):2684-91.